Weiss Multi-Strategy Advisers’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-8,831
| Closed | -$517K | – | 667 |
|
|
2021
Q4 | $517K | Sell |
8,831
-38
| -0.4% | -$2.23K | 0.01% | 528 |
|
|
2021
Q3 | $526K | Sell |
8,869
-2,131
| -19% | -$126K | 0.01% | 527 |
|
|
2021
Q2 | $955K | Sell |
11,000
-1,028
| -9% | -$89.2K | 0.02% | 475 |
|
|
2021
Q1 | $992K | Sell |
12,028
-2,972
| -20% | -$245K | 0.02% | 458 |
|
|
2020
Q4 | $1.36M | Sell |
15,000
-5,224
| -26% | -$475K | 0.03% | 428 |
|
|
2020
Q3 | $808K | Buy |
20,224
+224
| +1% | +$8.95K | 0.02% | 425 |
|
|
2020
Q2 | $686K | Buy |
20,000
+10,370
| +108% | +$356K | 0.02% | 427 |
|
|
2020
Q1 | $214K | Sell |
9,630
-370
| -4% | -$8.22K | 0.01% | 371 |
|
|
2019
Q4 | $196K | Sell |
10,000
-10,000
| -50% | -$196K | ﹤0.01% | 495 |
|
|
2019
Q3 | $311K | Hold |
20,000
| – | – | 0.01% | 418 |
|
|
2019
Q2 | $406K | Sell |
20,000
-3,500
| -15% | -$71.1K | 0.01% | 359 |
|
|
2019
Q1 | $413K | Buy |
23,500
+279
| +1% | +$4.9K | 0.01% | 375 |
|
|
2018
Q4 | $298K | Sell |
23,221
-6,779
| -23% | -$87K | 0.01% | 324 |
|
|
2018
Q3 | $489K | Buy |
+30,000
| New | +$489K | 0.01% | 362 |
|